ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The stock options carry an exercise price equal to the grant-date closing share price, rather than a discount.

Rhea-AI Summary

ImageneBio (Nasdaq: IMA) granted equity inducement awards to three newly hired non-executive employees on September 30, 2026, through its Compensation Committee.

The awards comprise 90,775 restricted stock units, which vest into shares, and 32,725 non-qualified stock options. Each option has a $4.58 exercise price, equal to the stock's closing price on the grant date. Both award types vest over four years, subject to continuous service through each vesting date. The grants were made under Nasdaq Listing Rule 5635(c)(4) and are subject to the company's 2025 Equity Inducement Plan and applicable award agreements.

Positive

• None.

Negative

• Minor point. Forward-looking: it has not happened yet and may not happen.90,775 restricted stock units create potential shareholder dilution as the employee awards vest.
• Minor point. Forward-looking: it has not happened yet and may not happen.32,725 non-qualified stock options at a $4.58 exercise price create potential dilution if exercised.

Key Figures

RSUs granted: 90,775 RSUs NSOs granted: 32,725 NSOs Award recipients: 3 employees +3 more

RSUs granted

90,775 RSUs

Inducement awards to three newly hired non-executive employees

NSOs granted

32,725 NSOs

Inducement awards to three newly hired non-executive employees

Award recipients

3 employees

Newly hired non-executive employees

NSO exercise price

$4.58 per share

Equal to the September 30, 2026 closing price

RSU vesting period

4 years

Schedules vary by employee; one schedule includes 12 quarterly installments after the first year

NSO vesting schedule

4 years; 25% after 1 year, remaining 75% over 36 months

Subject to continuous service through each vesting date

Historical Context

1 past event · Latest: Aug 17

1 event

1. Aug 17

   Inducement grants

   24h Move

   +1.8%

   Three new hires received 79,000 RSUs and 56,525 NSOs; options were priced at $5.84.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, non-qualified stock options

2 terms

restricted stock units financial

"awards consisting of 90,775 restricted stock units (“RSUs”)"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-qualified stock options financial

"32,725 non-qualified stock options (“NSOs”)"

Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on September 30, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of 90,775 restricted stock units (“RSUs”) and 32,725 non-qualified stock options (“NSOs”) to three newly hired non-executive employees. The foregoing inducement awards were granted as inducements material to the new employees entering into employment with Imagene in accordance with Nasdaq Listing Rule 5635(c)(4), and are subject to the terms and conditions of the Company’s 2025 Equity Inducement Plan and the applicable equity award agreements.

The RSUs for two of the employees vest in equal annual installments over four years, and the RSUs granted to one of the employees vest over four years with 25% of the RSUs vesting after one year and the balance of the RSUs vesting in 12 equal quarterly installments thereafter, in each case subject to the grantee’s continuous service through each vesting date. Each NSO has an exercise price equal to $4.58 per share, the closing price of Imagene’s common stock on September 30, 2026. The NSOs vest over four years, with 25% of the shares vesting after one year and the remaining 75% of the shares vesting in equal monthly installments over the following 36 months, subject to the grantee’s continuous service through each vesting date.

About ImageneBio, Inc.
Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics with differentiated clinical profiles for patients with immunological, autoimmune and inflammatory diseases. The Company’s program, olevaprubart, is a receptor targeting, non-depleting anti-OX40 monoclonal antibody with multiple differentiating features. Imagene has completed Phase 1b/2a clinical trials of olevaprubart in both atopic dermatitis and alopecia areata and is currently conducting a Phase 2b clinical trial of olevaprubart in patients with moderate-to-severe atopic dermatitis.

Company and Investor Contact
Rebecca Cohen
rcohen@imagenebio.com

Media Contact
Jason Braco, PhD
Valence Communications
jason@valencecomms.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity inducement awards did ImageneBio grant on September 30, 2026?

ImageneBio granted 90,775 restricted stock units and 32,725 non-qualified stock options to three newly hired non-executive employees. The options have an exercise price of $4.58 per share, equal to the closing stock price on September 30, 2026.

How do ImageneBio's September 2026 employee inducement awards vest?

All awards vest over four years, subject to continuous service through each vesting date. Two employees' restricted stock units vest in equal annual installments; the third employee's vest 25% after one year, then in 12 equal quarterly installments. Options vest 25% after one year, with the remaining 75% vesting monthly over the following 36 months.